BioCopy provides high-throughput analyses for the development of immunotherapeutics and novel vaccines in the field of oncology and infectious diseases. At BioCopy, we are convinced that this holds the key to the medicine of the future.
We combine next generation microarrays with our highSCORE system and measure the binding kinetic of thousands of molecules fast and label-free – on one single chip in one measurement.
If you need to find out “which molecule binds best”, BioCopy is your perfect match! Our unique technology is based on the team’s wide- ranging expertise in biochemistry and microsystems engineering.
Founded as a university spin-off in 2016, BioCopy is a multinational company headquartered in Switzerland with a large and modern R&D facility in Germany.
At BioCopy, we are defining new standards in our research and development. Work with us! Together, we can combine our technologies and expertise to develop the therapeutics of tomorrow.